These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10075070)

  • 1. A cost analysis of enterally administered lorazepam in the pediatric intensive care unit.
    Lugo RA; Chester EA; Cash J; Grant MJ; Vernon DD
    Crit Care Med; 1999 Feb; 27(2):417-21. PubMed ID: 10075070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison.
    McCollam JS; O'Neil MG; Norcross ED; Byrne TK; Reeves ST
    Crit Care Med; 1999 Nov; 27(11):2454-8. PubMed ID: 10579264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective.
    Swart EL; van Schijndel RJ; van Loenen AC; Thijs LG
    Crit Care Med; 1999 Aug; 27(8):1461-5. PubMed ID: 10470750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost.
    Cernaianu AC; DelRossi AJ; Flum DR; Vassilidze TV; Ross SE; Cilley JH; Grosso MA; Boysen PG
    Crit Care Med; 1996 Feb; 24(2):222-8. PubMed ID: 8605792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost analysis of enterally administered lorazepam in the pediatric intensive care unit "out of the orphanage".
    Schulman SR
    Crit Care Med; 1999 Feb; 27(2):266-7. PubMed ID: 10075047
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized controlled trial of interrupted versus continuous sedative infusions in ventilated children.
    Gupta K; Gupta VK; Jayashree M; Singhi S
    Pediatr Crit Care Med; 2012 Mar; 13(2):131-5. PubMed ID: 21283046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.
    Barrientos-Vega R; Mar Sánchez-Soria M; Morales-García C; Robas-Gómez A; Cuena-Boy R; Ayensa-Rincon A
    Crit Care Med; 1997 Jan; 25(1):33-40. PubMed ID: 8989173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients.
    MacLaren R; Sullivan PW
    Pharmacotherapy; 2005 Oct; 25(10):1319-28. PubMed ID: 16185175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit.
    Dasta JF; Kane-Gill SL; Pencina M; Shehabi Y; Bokesch PM; Wisemandle W; Riker RR
    Crit Care Med; 2010 Feb; 38(2):497-503. PubMed ID: 19789442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination.
    Richman PS; Baram D; Varela M; Glass PS
    Crit Care Med; 2006 May; 34(5):1395-401. PubMed ID: 16540957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of IV to Enteral Benzodiazepine Conversion Calculations in a Pediatric Intensive Care Setting.
    Warrington SE; Collier HK; Himebauch AS; Wolfe HA
    Pediatr Crit Care Med; 2018 Nov; 19(11):e569-e575. PubMed ID: 30080777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.
    Pandharipande PP; Pun BT; Herr DL; Maze M; Girard TD; Miller RR; Shintani AK; Thompson JL; Jackson JC; Deppen SA; Stiles RA; Dittus RS; Bernard GR; Ely EW
    JAMA; 2007 Dec; 298(22):2644-53. PubMed ID: 18073360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
    Barr J; Zomorodi K; Bertaccini EJ; Shafer SL; Geller E
    Anesthesiology; 2001 Aug; 95(2):286-98. PubMed ID: 11506097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
    Barr J; Donner A
    Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens.
    Shafer A
    Crit Care Med; 1998 May; 26(5):947-56. PubMed ID: 9590327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study.
    Pohlman AS; Simpson KP; Hall JB
    Crit Care Med; 1994 Aug; 22(8):1241-7. PubMed ID: 8045143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients.
    Lonardo NW; Mone MC; Nirula R; Kimball EJ; Ludwig K; Zhou X; Sauer BC; Nechodom K; Teng C; Barton RG
    Am J Respir Crit Care Med; 2014 Jun; 189(11):1383-94. PubMed ID: 24720509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of daily sedation interruption in critically ill children.
    Vet NJ; de Wildt SN; Verlaat CW; Knibbe CA; Mooij MG; van Woensel JB; van Rosmalen J; Tibboel D; de Hoog M
    Intensive Care Med; 2016 Feb; 42(2):233-44. PubMed ID: 26602782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost.
    Devlin JW; Holbrook AM; Fuller HD
    Ann Pharmacother; 1997 Jun; 31(6):689-95. PubMed ID: 9184706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.